BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 12788802)

  • 1. Androgens and cardiovascular disease.
    Liu PY; Death AK; Handelsman DJ
    Endocr Rev; 2003 Jun; 24(3):313-40. PubMed ID: 12788802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen therapy and atherosclerotic cardiovascular disease.
    McGrath KC; McRobb LS; Heather AK
    Vasc Health Risk Manag; 2008; 4(1):11-21. PubMed ID: 18629352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease and androgens: a review.
    Kaushik M; Sontineni SP; Hunter C
    Int J Cardiol; 2010 Jun; 142(1):8-14. PubMed ID: 19923015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is atherosclerotic cardiovascular disease an endocrinological disorder? The estrogen-androgen paradox.
    Phillips GB
    J Clin Endocrinol Metab; 2005 May; 90(5):2708-11. PubMed ID: 15687329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Androgens and cardiovascular disease: gender-related differences.
    Spoletini I; Caprio M; Vitale C; Rosano GM
    Menopause Int; 2013 Jun; 19(2):82-6. PubMed ID: 23761317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgens and cardiovascular disease.
    Yeap BB
    Curr Opin Endocrinol Diabetes Obes; 2010 Jun; 17(3):269-76. PubMed ID: 20186051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New perspectives on Mars and Venus: unravelling the role of androgens in gender differences in cardiovascular biology and disease.
    Ng MK
    Heart Lung Circ; 2007 Jun; 16(3):185-92. PubMed ID: 17448726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM; Saad F; Feeley RJ; Guay A
    J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular effect of testosterone replacement therapy in aging male.
    Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
    Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of estrogen/androgen regimens.
    Simon JA
    J Reprod Med; 2001 Mar; 46(3 Suppl):281-90. PubMed ID: 11304876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of androgens on the cardiovascular system.
    Rosano GM; Cornoldi A; Fini M
    J Endocrinol Invest; 2005; 28(3 Suppl):32-8. PubMed ID: 16042358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
    Jones TH; Kelly DM
    Asian J Androl; 2018; 20(2):120-130. PubMed ID: 29442075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal effects on blood vessels.
    Akishita M; Yu J
    Hypertens Res; 2012 Apr; 35(4):363-9. PubMed ID: 22297478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative impact of androgen and estrogen receptor activation in the effects of androgens on trabecular and cortical bone in growing male mice: a study in the androgen receptor knockout mouse model.
    Venken K; De Gendt K; Boonen S; Ophoff J; Bouillon R; Swinnen JV; Verhoeven G; Vanderschueren D
    J Bone Miner Res; 2006 Apr; 21(4):576-85. PubMed ID: 16598378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
    Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
    Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
    Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
    Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender differences in the cardiovascular effects of sex hormones.
    Vitale C; Fini M; Speziale G; Chierchia S
    Fundam Clin Pharmacol; 2010 Dec; 24(6):675-85. PubMed ID: 20199585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen-induced progression of arterial calcification in apolipoprotein E-null mice is uncoupled from plaque growth and lipid levels.
    McRobb L; Handelsman DJ; Heather AK
    Endocrinology; 2009 Feb; 150(2):841-8. PubMed ID: 19176322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormonal supplementation and erectile dysfunction.
    Aversa A; Isidori AM; Greco EA; Giannetta E; Gianfrilli D; Spera E; Fabbri A
    Eur Urol; 2004 May; 45(5):535-8. PubMed ID: 15082192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgens and bone.
    Vanderschueren D; Vandenput L; Boonen S; Lindberg MK; Bouillon R; Ohlsson C
    Endocr Rev; 2004 Jun; 25(3):389-425. PubMed ID: 15180950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.